UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2443) 2443
humans (2413) 2413
life sciences & biomedicine (2351) 2351
photosensitizing agents - therapeutic use (1418) 1418
female (1369) 1369
male (1304) 1304
photochemotherapy (1213) 1213
photodynamic therapy (1001) 1001
photochemotherapy - methods (908) 908
middle aged (900) 900
photosensitizing agents - adverse effects (828) 828
adult (755) 755
treatment outcome (741) 741
aged (736) 736
dermatology (723) 723
cancer (719) 719
animals (669) 669
photosensitizing agents - administration & dosage (663) 663
photochemotherapy - adverse effects (633) 633
ophthalmology (522) 522
photosensitizing agents - pharmacology (465) 465
care and treatment (433) 433
surgery (395) 395
aged, 80 and over (383) 383
aminolevulinic acid - therapeutic use (382) 382
porphyrins - therapeutic use (341) 341
oncology (330) 330
aminolevulinic acid - administration & dosage (294) 294
follow-up studies (289) 289
prospective studies (265) 265
aminolevulinic acid - analogs & derivatives (254) 254
biochemistry & molecular biology (251) 251
ultraviolet rays (249) 249
mice (244) 244
aminolevulinic acid - adverse effects (239) 239
fluorescein angiography (239) 239
adolescent (217) 217
choroidal neovascularization - drug therapy (215) 215
light (215) 215
photosensitizing agents - chemistry (202) 202
abridged index medicus (201) 201
analysis (200) 200
lasers (195) 195
young adult (194) 194
biophysics (192) 192
retrospective studies (190) 190
visual acuity (189) 189
internal medicine (188) 188
skin neoplasms - drug therapy (188) 188
time factors (183) 183
health aspects (168) 168
hematology, oncology and palliative medicine (166) 166
medicine & public health (166) 166
porphyrins - adverse effects (166) 166
research (164) 164
fluorescence (160) 160
visual acuity - physiology (160) 160
administration, topical (152) 152
cell line, tumor (152) 152
combined modality therapy (149) 149
clinical trials (148) 148
choroidal neovascularization - etiology (143) 143
dose-response relationship, drug (141) 141
photosensitizing agents (141) 141
ultraviolet rays - adverse effects (141) 141
pharmacology & pharmacy (140) 140
physical sciences (138) 138
collagen - metabolism (137) 137
keratosis, actinic - drug therapy (137) 137
macular degeneration (136) 136
riboflavin - therapeutic use (135) 135
photosensitizing agents - pharmacokinetics (134) 134
verteporfin (131) 131
chemistry (125) 125
tomography, optical coherence (123) 123
skin (121) 121
rats (119) 119
dentistry (115) 115
macular degeneration - drug therapy (112) 112
usage (111) 111
keratoconus - drug therapy (110) 110
skin cancer (109) 109
technology (109) 109
aminolevulinic acid (108) 108
cell survival - drug effects (107) 107
apoptosis (106) 106
eye diseases (103) 103
corneal stroma - metabolism (99) 99
macular degeneration - complications (98) 98
photosensitizing agents - toxicity (98) 98
actinic keratosis (96) 96
drug therapy (94) 94
porphyrins - administration & dosage (93) 93
carcinoma, basal cell - drug therapy (92) 92
skin - drug effects (92) 92
tumors (92) 92
5-aminolevulinic acid (85) 85
engineering (83) 83
pilot projects (82) 82
disease models, animal (81) 81
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2841) 2841
French (26) 26
German (21) 21
Spanish (18) 18
Japanese (12) 12
Russian (8) 8
Portuguese (7) 7
Polish (6) 6
Chinese (4) 4
Hungarian (3) 3
Norwegian (2) 2
Turkish (2) 2
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of clinical dermatology, ISSN 1175-0561, 02/2016, Volume 17, Issue 1, pp. 11 - 22
.... The primary outcomes were complete response and time to complete response. The secondary outcomes were partial response, relapse, time to relapse, reduction of itch, the adverse event rate, and withdrawal due to adverse events... 
Life Sciences & Biomedicine | Dermatology | Science & Technology | Antifungal Agents - adverse effects | Glucocorticoids - therapeutic use | Griseofulvin - adverse effects | Photosensitizing Agents - therapeutic use | Humans | Calcitriol - adverse effects | Griseofulvin - therapeutic use | Male | Photosensitizing Agents - adverse effects | Dermatologic Agents - therapeutic use | Ficusin - therapeutic use | Administration, Cutaneous | Enoxaparin - therapeutic use | Calcitriol - therapeutic use | Lichen Planus - drug therapy | Dermatologic Agents - adverse effects | Photochemotherapy | Enoxaparin - adverse effects | Antifungal Agents - therapeutic use | Calcitriol - analogs & derivatives | Fibrinolytic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Ficusin - adverse effects | Non-Randomized Controlled Trials as Topic | Female | Acitretin - therapeutic use | Lichen Planus - radiotherapy | Acitretin - adverse effects | Glucocorticoids - adverse effects | Sulfasalazine - therapeutic use | Keratolytic Agents - therapeutic use | Lichen Planus - therapy | Keratolytic Agents - adverse effects | Treatment Outcome | Randomized Controlled Trials as Topic | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | PUVA Therapy | Sulfasalazine - adverse effects
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2010, Volume 54, Issue 9, pp. 3834 - 3841
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article